PHAT - Phathom Pharmaceuticals GAAP EPS of -$1.33 beats by $0.01
- Phathom Pharmaceuticals press release ( NASDAQ: PHAT ): Q4 GAAP EPS of -$1.33 beats by $0.01 .
- As of December 31, 2022, cash and cash equivalents were $155.4 million. An additional $100 million is available under Phathom’s term loan with Hercules Capital.
For further details see:
Phathom Pharmaceuticals GAAP EPS of -$1.33 beats by $0.01